-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMMIT THERAPEUTICS ANNOUNCES CLINICAL TRIAL COLLABORATION WITH ASTRAZENECA AND DAIICHI SANKYO TO EVALUATE IVONESCIMAB IN COMBINATION WITH TROP2-DIRECTED ADC DATROWAY

Reuters·10/02/2026 06:30:00

Please log in to view news